Guardian Pharmacy Services, Inc. (NYSE:GRDN) Receives $32.00 Consensus Target Price from Analysts

Guardian Pharmacy Services, Inc. (NYSE:GRDN) has earned an average recommendation of “Moderate Buy” from the five brokerages that are covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1 year target price among brokers that have issued ratings on the stock in the last year is $32.00.

A number of equities research analysts have recently weighed in on GRDN shares. Stephens lifted their price objective on Guardian Pharmacy Services from $35.00 to $36.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 14th. Wall Street Zen upgraded Guardian Pharmacy Services from a “buy” rating to a “strong-buy” rating in a report on Monday, November 17th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Guardian Pharmacy Services in a research note on Monday, December 29th. Finally, Truist Financial boosted their price objective on shares of Guardian Pharmacy Services from $30.00 to $34.00 and gave the company a “buy” rating in a research report on Friday, November 14th.

Institutional Investors Weigh In On Guardian Pharmacy Services

A number of large investors have recently modified their holdings of GRDN. Ameritas Investment Partners Inc. increased its position in shares of Guardian Pharmacy Services by 26.5% during the third quarter. Ameritas Investment Partners Inc. now owns 1,647 shares of the company’s stock valued at $43,000 after buying an additional 345 shares during the period. California State Teachers Retirement System lifted its holdings in Guardian Pharmacy Services by 3.4% in the fourth quarter. California State Teachers Retirement System now owns 17,983 shares of the company’s stock worth $541,000 after buying an additional 593 shares during the period. Envestnet Asset Management Inc. boosted its position in Guardian Pharmacy Services by 7.1% during the 2nd quarter. Envestnet Asset Management Inc. now owns 12,126 shares of the company’s stock valued at $258,000 after acquiring an additional 805 shares in the last quarter. Police & Firemen s Retirement System of New Jersey boosted its position in Guardian Pharmacy Services by 20.4% during the 4th quarter. Police & Firemen s Retirement System of New Jersey now owns 6,070 shares of the company’s stock valued at $183,000 after acquiring an additional 1,028 shares in the last quarter. Finally, State of Alaska Department of Revenue purchased a new position in shares of Guardian Pharmacy Services during the 3rd quarter worth approximately $30,000.

Guardian Pharmacy Services Price Performance

GRDN opened at $32.29 on Thursday. The business has a 50 day simple moving average of $31.66 and a two-hundred day simple moving average of $29.23. The firm has a market capitalization of $2.04 billion, a price-to-earnings ratio of 51.25 and a beta of 0.85. Guardian Pharmacy Services has a one year low of $18.00 and a one year high of $37.43.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.